{"id":"https://openalex.org/W2000943484","doi":"https://doi.org/10.1038/309056a0","title":"Human large granular lymphocytes are potent producers of interleukin-1","display_name":"Human large granular lymphocytes are potent producers of interleukin-1","publication_year":1984,"publication_date":"1984-05-01","ids":{"openalex":"https://openalex.org/W2000943484","doi":"https://doi.org/10.1038/309056a0","mag":"2000943484","pmid":"https://pubmed.ncbi.nlm.nih.gov/6609314"},"language":"en","primary_location":{"id":"doi:10.1038/309056a0","doi":"https://doi.org/10.1038/309056a0","is_oa":false,"landing_page_url":"https://doi.org/10.1038/309056a0","pdf_url":null,"source":{"id":"https://openalex.org/S137773608","display_name":"Nature","issn_l":"0028-0836","issn":["0028-0836","1476-4687"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001102777","display_name":"Giuseppe Scala","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Giuseppe Scala","raw_affiliation_strings":["Laboratory of Molecular Immunoregulation, National Cancer Institute\u2013Frederick Cancer Research Facility, Frederick, Maryland, 21701, USA","Laboratory of Molecular Immunoregulation, National Cancer Institute\u2013Frederick Cancer Research Facility, Frederick, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Immunoregulation, National Cancer Institute\u2013Frederick Cancer Research Facility, Frederick, Maryland, 21701, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Laboratory of Molecular Immunoregulation, National Cancer Institute\u2013Frederick Cancer Research Facility, Frederick, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065211137","display_name":"Paola Allavena","orcid":"https://orcid.org/0000-0002-6697-6028","observed_orcids":["https://orcid.org/0000-0002-6697-6028"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paola Allavena","raw_affiliation_strings":["Biological Therapeutics Branch, Biological Response Modifiers Program, National Cancer Institute\u2013Frederick Cancer Research Facility, Frederick, Maryland, 21701, USA","Biological Therapeutics Branch, Biological Response Modifiers Program, National Cancer Institute\u2013Frederick Cancer Research Facility, Frederick, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Therapeutics Branch, Biological Response Modifiers Program, National Cancer Institute\u2013Frederick Cancer Research Facility, Frederick, Maryland, 21701, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Biological Therapeutics Branch, Biological Response Modifiers Program, National Cancer Institute\u2013Frederick Cancer Research Facility, Frederick, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112224771","display_name":"Julie Y. Djeu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie Y. Djeu","raw_affiliation_strings":["Office of Biologics, National Center for Drugs and Biologics, Food and Drug Administration, Bethesda, Maryland, 20205, USA","Office of Biologics, National Center for Drugs and Biologics, Food and Drug Administration, Bethesda, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of Biologics, National Center for Drugs and Biologics, Food and Drug Administration, Bethesda, Maryland, 20205, USA","institution_ids":["https://openalex.org/I1320320070"]},{"raw_affiliation_string":"Office of Biologics, National Center for Drugs and Biologics, Food and Drug Administration, Bethesda, USA","institution_ids":["https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101777381","display_name":"Tadashi Kasahara","orcid":"https://orcid.org/0000-0001-7687-5477","observed_orcids":["https://orcid.org/0000-0001-7687-5477"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210088259","display_name":"National Institute of Dental and Craniofacial Research","ror":"https://ror.org/004a2wv92","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210088259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tadashi Kasahara","raw_affiliation_strings":["Laboratory of Microbiology and Immunology, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland, 20205, USA","Laboratory of Microbiology and Immunology, National Institute of Dental Research, National Institutes of Health, Bethesda, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Microbiology and Immunology, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland, 20205, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210088259"]},{"raw_affiliation_string":"Laboratory of Microbiology and Immunology, National Institute of Dental Research, National Institutes of Health, Bethesda, USA","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019215357","display_name":"John R. Ortaldo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John R. Ortaldo","raw_affiliation_strings":["Biological Therapeutics Branch, Biological Response Modifiers Program, National Cancer Institute\u2013Frederick Cancer Research Facility, Frederick, Maryland, 21701, USA","Biological Therapeutics Branch, Biological Response Modifiers Program, National Cancer Institute\u2013Frederick Cancer Research Facility, Frederick, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Therapeutics Branch, Biological Response Modifiers Program, National Cancer Institute\u2013Frederick Cancer Research Facility, Frederick, Maryland, 21701, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Biological Therapeutics Branch, Biological Response Modifiers Program, National Cancer Institute\u2013Frederick Cancer Research Facility, Frederick, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112523801","display_name":"Ronald B. Herberman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronald B. Herberman","raw_affiliation_strings":["Biological Therapeutics Branch, Biological Response Modifiers Program, National Cancer Institute\u2013Frederick Cancer Research Facility, Frederick, Maryland, 21701, USA","Biological Therapeutics Branch, Biological Response Modifiers Program, National Cancer Institute\u2013Frederick Cancer Research Facility, Frederick, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Therapeutics Branch, Biological Response Modifiers Program, National Cancer Institute\u2013Frederick Cancer Research Facility, Frederick, Maryland, 21701, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Biological Therapeutics Branch, Biological Response Modifiers Program, National Cancer Institute\u2013Frederick Cancer Research Facility, Frederick, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042240287","display_name":"Joost J. Oppenheim","orcid":"https://orcid.org/0000-0003-0271-7921","observed_orcids":["https://orcid.org/0000-0003-0271-7921"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joost J. Oppenheim","raw_affiliation_strings":["Laboratory of Molecular Immunoregulation, National Cancer Institute\u2013Frederick Cancer Research Facility, Frederick, Maryland, 21701, USA","Laboratory of Molecular Immunoregulation, National Cancer Institute-Frederick Cancer Research Facility, Frederick, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Immunoregulation, National Cancer Institute\u2013Frederick Cancer Research Facility, Frederick, Maryland, 21701, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Laboratory of Molecular Immunoregulation, National Cancer Institute-Frederick Cancer Research Facility, Frederick, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":12690,"currency":"USD","value_usd":12690},"apc_paid":null,"fwci":14.7825,"has_fulltext":false,"cited_by_count":208,"citation_normalized_percentile":{"value":0.99489989,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"309","issue":"5963","first_page":"56","last_page":"59"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/large-granular-lymphocytes","display_name":"large granular lymphocytes","score":0.9990000128746033},{"id":"https://openalex.org/keywords/interleukin-1","display_name":"interleukin-1","score":0.9110000133514404},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.9660000205039978},{"id":"https://openalex.org/keywords/nk-cell-cytotoxicity","display_name":"NK cell cytotoxicity","score":0.5519999861717224},{"id":"https://openalex.org/keywords/cytokine-production","display_name":"cytokine production","score":0.7829999923706055},{"id":"https://openalex.org/keywords/lymphokines","display_name":"lymphokines","score":0.6039999723434448},{"id":"https://openalex.org/keywords/immune-regulation","display_name":"immune regulation","score":0.8349999785423279},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.5529999732971191},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.796999990940094},{"id":"https://openalex.org/keywords/interferon","display_name":"interferon","score":0.8019999861717224}],"concepts":[{"id":"https://openalex.org/C49382859","wikidata":"https://www.wikidata.org/wiki/Q286498","display_name":"Lymphokine","level":3,"score":0.8498034477233887},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.552861750125885},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5280212759971619},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.48461708426475525},{"id":"https://openalex.org/C28651165","wikidata":"https://www.wikidata.org/wiki/Q4259786","display_name":"Lymphokine-activated killer cell","level":5,"score":0.46296170353889465},{"id":"https://openalex.org/C2778102761","wikidata":"https://www.wikidata.org/wiki/Q332181","display_name":"Natural killer cell","level":4,"score":0.4466029107570648},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.4344891905784607},{"id":"https://openalex.org/C49039625","wikidata":"https://www.wikidata.org/wiki/Q84230","display_name":"Secretion","level":2,"score":0.4309577941894531},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.4145287275314331},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.41345033049583435},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4119243025779724},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.38188636302948},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3233596682548523},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3048769533634186},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.1885850429534912},{"id":"https://openalex.org/C129374314","wikidata":"https://www.wikidata.org/wiki/Q909381","display_name":"Interleukin 21","level":4,"score":0.18847811222076416},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.17218446731567383},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12285631895065308}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002469","descriptor_name":"Cell Separation","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D002501","descriptor_name":"Centrifugation, Zonal","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007375","descriptor_name":"Interleukin-1","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008214","descriptor_name":"Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1038/309056a0","doi":"https://doi.org/10.1038/309056a0","is_oa":false,"landing_page_url":"https://doi.org/10.1038/309056a0","pdf_url":null,"source":{"id":"https://openalex.org/S137773608","display_name":"Nature","issn_l":"0028-0836","issn":["0028-0836","1476-4687"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature","raw_type":"journal-article"},{"id":"pmid:6609314","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6609314","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W77478039","https://openalex.org/W1503075228","https://openalex.org/W1504875452","https://openalex.org/W1510592856","https://openalex.org/W1523175658","https://openalex.org/W1534220439","https://openalex.org/W1535721264","https://openalex.org/W1543285514","https://openalex.org/W1550447653","https://openalex.org/W1564432735","https://openalex.org/W1602400123","https://openalex.org/W1605611339","https://openalex.org/W1987240692","https://openalex.org/W2002328752","https://openalex.org/W2002594142","https://openalex.org/W2012918825","https://openalex.org/W2027581129","https://openalex.org/W2027922729","https://openalex.org/W2031855019","https://openalex.org/W2045964137","https://openalex.org/W2059168808","https://openalex.org/W2061954876","https://openalex.org/W2072558223","https://openalex.org/W2088443429","https://openalex.org/W2097445369","https://openalex.org/W2102520206","https://openalex.org/W2104518210","https://openalex.org/W2123463399","https://openalex.org/W2144291634","https://openalex.org/W2144743138","https://openalex.org/W2161082695","https://openalex.org/W6638429528"],"related_works":["https://openalex.org/W2979774273","https://openalex.org/W1534220439","https://openalex.org/W2036329236","https://openalex.org/W2001237289","https://openalex.org/W1983088152","https://openalex.org/W1967566995","https://openalex.org/W2403727753","https://openalex.org/W7134687208","https://openalex.org/W1540514074","https://openalex.org/W280265164"],"abstract_inverted_index":null,"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}